Trinbelimab

Product Name: Trinbelimab
CAS No.: 2415078-44-1
Chemical Name: Trinbelimab
Synonyms: Trinbelimab;Research Grade Trinbelimab;Research Grade Trinbelimab (DHF92104)
CBNumber: CB110617110
Formula Weight: 0
MOL File: Mol file

More

Less

Hazard and Precautionary Statements (GHS)

More

Less

Trinbelimab Chemical Properties,Usage,Production

Uses

Trinbelimab (r-anti-D) is an antibody. Trinbelimab can be used for various biochemical studies[1].

References

[1] Rahul Vishwanath Mayekar, et al. Recombinant anti-D for prevention of maternal-foetal Rh(D) alloimmunization: a randomized multi-centre clinical trial. Obstet Gynecol Sci. 2020 May;63(3):315-322. DOI:10.5468/ogs.2020.63.3.315

Trinbelimab Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

Trinbelimab Suppliers

China 8 Global 8

ShangHai Biochempartner Co.,Ltd

Tel: 177-54423994 17754423994
Fax: QQ:2853530913
Email: 2853530910@QQ.com
Country: China
ProdList: 8000
Advantage: 62

Guangzhou Hongyuan Chemical Co.,Ltd

Tel: 15817493340
Email: 981810490@qq.com
Country: China
ProdList: 1566
Advantage: 58

Wuhan Chemstan Biotechnology Co., Ltd.

Tel: 027-65317797 15926423062
Fax: QQ：422450190
Email: 422450190@qq.com
Country: China
ProdList: 10308
Advantage: 58

Biolab Reagents

Tel: 027-65279366 18108604356
Email: products@biolabreagent.com
Country: China
ProdList: 9868
Advantage: 58

Wanxin Biotechnology (Jiaxing) Co., LTD

Tel: 0573-83568680 18057391398
Email: 3956524501@qq.com
Country: China
ProdList: 1442
Advantage: 58

Atagenix Laboratories

Tel: 027-87008169 17762441161
Email: info@atagenix.com
Country: China
ProdList: 10001
Advantage: 58

AntibodySystem Laboratories SAS

Tel: 33175446423
Email: support@antibodysystem.com
Country: China
ProdList: 6739
Advantage: 58

Cell Sciences

Tel: 9785721070
Email: info@cellsciences.com
Country: China
ProdList: 6308
Advantage: 58

2415078-44-1, TrinbelimabRelated Search:

Romilkimab Laprituximab Minretumomab [inn] Mavezelimab Bedinvetmab Sudubrilimab Xeligekimab Sirtratumab Tabituximab Dilpacimab

Trinbelimab

Research Grade Trinbelimab (DHF92104)

Research Grade Trinbelimab

2415078-44-1